Craig Johnson
Director/Board Member at TETRAPHASE PHARMACEUTICALS, INC.
Net worth: 132 274 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Kevin Tang | M | 57 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 30 years |
Michael Hearne | M | 61 | 9 years | |
Aaron Davis | M | 45 | 8 years | |
Craig Collard | M | 58 | 1 years | |
Adam Morgan | M | 45 | 1 years | |
Sandra Ramos-Alves | F | - | - | |
Kimberly McCutcheon Jablonski | F | - | - | |
Ryan Cole | M | - | 10 years | |
Sharmila Dissanaike | M | 49 | 3 years | |
Thomas B. Ottoboni | M | 65 | 12 years | |
Susan Rodriguez | F | 60 | 3 years | |
Christian Waage | M | 57 | 8 years | |
Paul Reider | M | 55 | - | |
Tony Hodges | M | - | 3 years | |
Paula Rusu | F | - | 4 years | |
Sophia Park | F | - | - | |
Joseph Solomkin | M | - | - | |
William Forbes | M | 62 | 1 years | |
Pavel Raifeld | M | 40 | 2 years | |
Chris Storgard | M | 58 | 6 years | |
Sean T. Ristine | M | 54 | 10 years | |
Marianne Zhen | F | 55 | 2 years | |
Konstantina Katcheves | F | - | - | |
Ira Duarte | F | 55 | 1 years | |
Steven Pfeiffer | M | 48 | 8 years | |
Luke Seikkula | M | 60 | 5 years | |
John C. Arthur | M | 58 | 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Larry G. Edwards | M | 52 | 8 years | |
Henry Fuchs | M | 66 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 27 years |
Kim Tsuchimoto | F | 61 | - | |
David Szekeres | M | 50 | 7 years | |
Robert H. Rosen | M | 68 | 10 years | |
John W. Poyhonen | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
George Tidmarsh | M | 64 | 7 years | |
Stephen Davis | M | 63 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 10 years |
Christopher Starr | M | 71 | 7 years | |
Barry Quart | M | 67 | 11 years | |
Laura Douglass | F | 59 | 9 years | |
Charles Baum | M | 65 | 12 years | |
Lisa Peraza | F | 47 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 16 years |
Robert Davis | M | 73 |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | 6 years |
Rodney Lappe | M | 69 | 7 years | |
Erich Sager | M | 66 | 6 years | |
Mark Gergen | M | 61 | 3 years | |
Perry Johnston | M | - | - | |
Richard Williams | M | 80 | 9 years | |
Kimberly Manhard | F | 64 | 9 years | |
Todd C. Zankel | M | 60 |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | 3 years |
Neil M. Kurtz | M | 73 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 5 years |
Llew Keltner | M | 74 | 7 years | |
Evelyn A. Graham | F | 75 |
TPTX, Inc.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 3 years |
Dennis Mulroy | M | 69 | 5 years | |
Vickie Reed | F | 62 | 9 years | |
Martin Godbout | M | - | 12 years | |
Esmé c. Smith | F | 52 | - | |
Maria D. Stahl | F | 53 | 5 years | |
Jeffrey Jensen | M | - | - | |
Neil Reisman | M | 62 | 1 years | |
Tina Nova | M | 70 | 3 years | |
Felix Baker | M | 55 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 2 years |
John Lemkey | M | 43 | 7 years | |
John Moriarty | M | 56 | - | |
Karen A. Klause | F | - | - | |
David Meek | M | 59 | 2 years | |
Marcy Graham | F | 57 | - | |
Jeffrey Chodakewitz | M | 68 | 6 years | |
Jennifer Carver | F | 70 | 5 years | |
Daniel Faga | M | 44 | 1 years | |
Temre Johnson | M | - | 5 years | |
Shubh Goel | M | 51 | - | |
Maya Martinez-Davis | F | 54 | 6 years | |
Inge Bear | F | - | - | |
Michael Grey | M | 71 | 7 years | |
Shalini Sharp | F | 49 | 3 years | |
Walter Moos | M | 69 |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | 7 years |
Wendy Dixon | M | 68 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 1 years |
Robert B. Rothermel | M | 80 | 5 years | |
William C. Denby | M | 69 | 5 years | |
Nancy Wysenski | F | 66 | 6 years | |
John Freund | M | 70 | 8 years | |
Carol Gallagher | M | 59 | 1 years | |
Patrick van Beneden | M | 62 |
TPTX, Inc.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 6 years |
Faheem Hasnain | M | 65 | 5 years | |
Jean Deleage | M | 83 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA.
TPTX, Inc.
| 9 years |
Leonard Patrick Gage | M | 81 | 9 years | |
Raymond Anderson | M | 82 | 7 years | |
Bruce Carter | M | 80 | 8 years | |
Kenneth M. Cohen | M | 68 | 3 years | |
Brian Drazba | M | 63 | 4 years | |
Jack S. Remington | M | 93 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
Peter Davis | M | 79 |
TPTX, Inc.
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | 4 years |
Michael A. Adam | M | 66 | 5 years | |
William Ringo | M | 78 | 2 years | |
Mark Flather | M | - | 8 years | |
Garen Bohlin | M | 76 | 10 years | |
Michael Murphy | M | 65 |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA.
TPTX, Inc.
| 2 years |
John W. Beck | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 years |
Rick Franklin | M | 78 | 7 years | |
Julie Cherrington | M | 66 | 5 years | |
Reena Desai | F | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Craig Johnson
- Personal Network